Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AP31969 DDI Study with Carbamazepine and Itraconazole
NCT07449390Phase 1Completed
- Sponsor
- Acesion Pharma
- Start
- Apr 2026
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of AP31969 (2 arms), sponsored by Acesion Pharma. Primary endpoints: Maximum Observed Plasma Concentration, Area Under the Plasma Concentration-time Curve from Time 0 to Time of Last Quantifiable Concentration and 1 more. Started Apr 2026; status: completed.
02
Drugs
AP31969
Beyond the preview
Go deeper on NCT07449390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07449390.